September 1, 2025 Teva Pharmaceuticals achieved a landmark milestone when the US Food and Drug Administration (FDA) approved a first-of-its-kind launch of a generic glucagon-like peptide-1 (GLP-1)
The FDA approves the active pharmaceutical ingredient (semaglutide) for use in specific brand-name products (Ozempic, Wegovy, Rybelsus), but the compounded formulations produced by compounding pharmacies for individual prescriptions operate under a different regulatory framework
K., Alfert M., Castrillon D
While most supplements seem harmless, some can interact with these medications in ways that lead to unwelcome side effects think gastrointestinal (GI) issues, nutrient deficiencies or even dangerously low blood sugar
Effective dosing of L-carnitine in the secondary prevention of cardiovascular disease: a systematic review and meta-analysis